Treatment options for primary constipation

被引：10
作者：
Pampati V. [1 ]
Fogel R. [1 ]
机构：
[1] Division of Gastoenterology, Henry Ford Hospital, Detriot, MI 48202
来源：
Current Treatment Options in Gastroenterology | 2004年 / 7卷 / 3期
关键词：
Constipation; Irritable Bowel Syndrome; Main Side Effect; Main Drug Interaction; Tegaserod;
D O I：
10.1007/s11938-004-0043-z
中图分类号：
学科分类号：
摘要：
Patients suffering from primary constipation often show symptom improvement with increased intake of fiber. Bulk laxatives are a core component of treatment if dietary fiber is unsuccessful in alleviating symptoms. Although there are a number of commercial laxative preparations available, only polyethylene glycol (PEG), an osmotic laxative, should be used on a daily basis. For the elderly, saline laxatives may be used on a regular basis, provided there are no cardiac or renal comorbid contraindications. Tegaserod, a 5-HT4 partial receptor agonist, is approved for the treatment of constipation in female patients. The appropriate role of biofeedback remains to be determined. Surgery should be reserved for patients with slow transit constipation refractory to medical therapy. Patients being considered for surgery should be evaluated at institutions with substantial expertise in the investigation and management of this population. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：225 / 233
页数：8
相关论文
共 42 条
  • [11] Marlett J.A., McBurney M.I., Slavin J.L., Position of the ADA: Health implications of dietary fiber, J. Am. Dietetic Assoc., 102, pp. 993-1000, (2002)
  • [12] Dietary Functional and Total Fiber in Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids
  • [13] Voderhozer W.A., Schatke W., Muhldorfer B.E., Et al., Clinical response to dietary fiber treatment of chronic constipation, Am. J. Gastroenterol., 92, pp. 95-98, (1997)
  • [14] Xing J.H., Soffer E.E., Adverse effects of laxatives, Dis. Colon. Rectum., 44, pp. 1201-1209, (2001)
  • [15] DiPalma J.A., DeRidder P.H., Orlando R.C., Et al., A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative, Am. J. Gastroenterol., 95, pp. 446-450, (2000)
  • [16] Wald A., Is chronic use of stimulant laxatives harmful to the colon?, J. Clin. Gastroenterol., 36, pp. 386-389, (2003)
  • [17] Joo J.S., Ehrenpreis E.D., Gonzalez L., Et al., Alterations in colonic anatomy induced by chronic stimulant laxatives: The cathartic colon revisited, J. Clin. Gastroenterol., 26, pp. 283-286, (1998)
  • [18] Muller-Lissner S., What has happened to the cathartic colon?, Gut, 39, pp. 486-488, (1996)
  • [19] Sonnenberg A., Muller A.D., Constipation and cathartics as risk factors of colorectal cancer
  • [20] a meta-analysis, Pharmacology, 47, SUPPL. 1, pp. 224-233, (1993)
12345